IMCD nominates new Supervisory Board member and publishes EGM convocation
October 13 2023 - 12:00PM
IMCD nominates new Supervisory Board member and publishes EGM
convocation
ROTTERDAM, The Netherlands (13 October 2023, 18:00 CEST)
– IMCD N.V. ("IMCD" or "Company"), a global leading
distribution partner, formulator of speciality chemicals and
ingredients, announces that its Supervisory Board has nominated
Mrs. Dorthe Mikkelsen for appointment as member of the Supervisory
Board. This appointment proposal will be presented to the
shareholders for their approval in an Extraordinary General Meeting
(EGM) to be held on 27 November 2023.
The nomination of Mrs. Mikkelsen is in response to the vacancy
arisen by the resignation of Mrs. Valerie Diele-Braun, who has
assumed her role as member of the Management Board as of 1 October
and will be succeeding Piet van der Slikke as CEO of IMCD as of
January 2024.
Dorthe Mikkelsen (1967) has the Danish nationality and
holds a degree in marketing from Copenhagen Business
School and a master's degree in pharmacy from the Royal Danish
School of Pharmacy. She is an experienced business leader and
seasoned international executive in the pharmaceutical and
healthcare industry. After starting her career at Novo Nordisk,
Mrs. Mikkelsen joined MSD (Merck, Sharp & Dohme), one of the
leading pharmaceutical companies in the world, where she held
various management positions in over 25 years. Most recently, Mrs.
Mikkelsen served as Senior Vice President and President Asia
Pacific, with P&L responsibility for revenue of over EUR 2.3
billion and 3,500 employees (with oversight of total 7,000
employees).
In 2021, Mrs Mikkelsen relocated back to Denmark and focussed on
non-executive roles. She is currently a non-executive director at
Falck, a global healthcare provider with operations in 26 countries
in Europe, USA, and Latin America, where she is also a member of
the Audit Committee and Remuneration & Appointment Committee.
In addition, she is a non-executive director at Theramex, a leading
global speciality pharmaceutical company dedicated to women’s
health, where Mrs. Mikkelsen also chairs the Remuneration
Committee.
Her industry-knowledge, in particular in the pharmaceuticals
market segment, and international experience are deemed a valuable
contribution to the Supervisory Board’s composition. Her expertise
gained in current non-executive roles will furthermore strengthen
the Supervisory Board as a whole.
Further details on the nomination are included in the
documentation for the EGM, that is published on IMCD's website
here.
Attached, the press release in pdf format.
- xxx -
This press release contains information that qualifies as inside
information within the meaning of Article 7(1) of the EU Market
Abuse Regulation and was issued on 13 October 2023, 18:00 hrs
CEST.
About IMCD N.V.
IMCD N.V. based in Rotterdam, The Netherlands, is a leading
global distribution partner and formulator of speciality chemicals
and ingredients. IMCD is an expert solutions provider and adds
sustainable value to the supply chain. Every day professionals
focus on providing the best service through commercial and
operational excellence. The company is mindful of the role they
play in creating a better planet for all and formulates with
consciousness and executes with care, to address business
challenges of tomorrow, in partnership and transparency.
In 2022, with over 4,300 employees, IMCD realised a revenue of
EUR 4,601 million. IMCD N.V.’s shares are traded at Euronext,
Amsterdam (symbol: IMCD) and included in the Dutch ESG AEX index,
as one of 25 companies within the AEX and AMX indices demonstrating
best ESG practices. For further information, please
visit www.imcdgroup.com.
Media contact
IMCD Group Marnie KontovrakiCorporate Communications Director
+31 10 290 86 84mediarelations@imcdgroup.com
IR contact
IMCD N.V. Cecile WesterhuisCompany Secretary+31 10 290 86
84ir@imcdgroup.com
- PR - IMCD nominates new Supervisory Board member and publishes
EGM convocation
IMCD NV (TG:INX)
Historical Stock Chart
From Jan 2025 to Feb 2025
IMCD NV (TG:INX)
Historical Stock Chart
From Feb 2024 to Feb 2025